Angelalign Technology Inc. is a global provider of clear aligner technology, production, and sales. The company develops and markets orthodontic solutions, including the masterForce system, masterControl materials, and the iOrtho platform, alongside specific product lines such as A6, A7, and A8. Its operations are divided into the Chinese mainland market and global markets outside of China. Key subsidiaries include Wuxi EA, Shanghai EA Medical Instruments Co. Ltd., Angelalign Technology Pte. Ltd., and Aditek. The company was incorporated in 2018 and listed on the Main Board of the Stock Exchange in 2021.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Medical Devices Homepage angelalign.com
Sector Healthcare IR page angelalign.com/investor-relationship
Tags
orthodontics, clear aligners, dental appliances, digital dentistry, oral healthcare, masterForce, masterControl, masterControl S, iOrtho, A6, A7, A8, Wuxi EA, Shanghai EA Medical Instruments Co. Ltd., Angelalign Technology Pte. Ltd., Aditek
Press page —

Metrics

Valuation  
Market cap HK$ 13.02B
Market cap (USD) $ 1.659B
P/E 57.62
PEG —
P/BV 4.00
P/S 3.77
P/OCF 14.52
P/FCF —
Dividend yield 13.3%
Turnover / mcap 0.30%
Returns  
ROE 5.8%
ROI 5.6%
ROIC 6.0%
Profit margin 7.7%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -3.1%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 17.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 23.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 370.281M 268.787M 203.725M 185.345M 196.571M 118.044M 92.077M 71.769M
Net profit 28.437M 12.114M 7.381M 31.207M 44.185M 21.785M 9.813M 8.78M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price 8.56 7.61 8.34 14.72 18.55 — — —
Price performance 12m 0.12 -0.09 -0.44 -0.2 — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

时间:2026-10-18

北京时间2026年10月17日,时代天使科技有限公司(6699.HK,以下简称“时代天使”)表示,欧洲统一专利法院巴黎地方分院就其“转矩嵴”(Torque Ridges)功能作出的裁决,不影响公司在欧洲的产品供应,时代天使尊重法院的裁决,但对该裁决持有不同意见,目前正在仔细审阅裁决,并评估可采取的措施。目前,时代天使在欧洲提供的产品已采用新一代转矩控制技术。西班牙、英国以及欧洲以外地区(包括美洲和亚洲)的时代天使客户均不受本次裁决影响。

今年9月,时代天使发布历时三年研发验证的新一代精控“压力点”(Pressure Points)系统。该技术聚焦隐形正畸临床转矩、扭转控制痛点,对阴性附件体系完成升级,目前已率先在欧洲市场投入临床使用,为当地正畸医生带来精度更高、体验更优的数字化矫治工具。“压力点”功能的升级迭代,是时代天使坚持以创新持续解决正畸医生临床挑战的承诺体现。公司将始终持续开发新的解决方案,为客户提供优质服务。

一直以来,时代天使高度重视知识产权保护,审慎开展相关工作,避免侵犯有效专利。尽管面临竞争对手提起的诉讼,时代天使仍将继续创新和改进产品,让使用公司产品的医生与患者受益。

Prompts

Angelalign Technology Inc. (ticker 6699), listed in Hong Kong.

Company History

Date Change Detail
Jun 30, 2025 Reporting currency Its HK reports are in USD instead of CNY from this period. Earlier figures are shown in USD, converted at each period end's exchange rate.

ETFs Holding Angelalign Technology Inc.

ETF Weight in ETF Shares Market value As of
AVEE 0.02% 3,200 $ 32.607K Nov 16, 2026
AVEM 0.01% 144,000 $ 1.467M Nov 16, 2026
DFSE 0.01% 5,400 $ 54.656K Nov 12, 2026
DFAE 0.01% 59,800 $ 605.269K Nov 12, 2026
DFEM 0.01% 56,200 $ 568.831K Nov 12, 2026
DFAX 0.00% 23,200 $ 234.82K Nov 12, 2026